Galera Therapeutics, Inc. (GRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0240
-0.0012 (-4.76%)
At close: Dec 5, 2025
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of December 31, 2024. The number of employees decreased by 4 or -57.14% compared to the previous year.
Employees
3
Change (1Y)
-4
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$2,995,333
Market Cap
1.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Galera Therapeutics News
- 6 weeks ago - Galera Therapeutics (GRTX) Sells Asset Portfolio to Biossil - GuruFocus
- 6 weeks ago - Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million - GlobeNewsWire
- 1 year ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 1 year ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 1 year ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 years ago - Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire